• Home
  • / Whitepapers
  • / Simoa® NF-light™: Ultrasensitive Blood-Based Biomarker Detection for Identification of Neuropathology
circle animation
circle animation
circle animation
circle animation
Neurology

Simoa® NF-light™: Ultrasensitive Blood-Based Biomarker Detection for Identification of Neuropathology

Posted on

Download App Note
Survivors of cardiac arrest and prolonged open-heart surgery have increased risks of developing adverse neurological outcomes in the long term1,2. Identifying high-risk patients at an early stage allows clinicians to propose better therapeutic strategies, resulting in significant improvements in patient management and quality of life. Download our app note to learn how detection of NfL with Simoa® can support the identification of neuropathology and could help improve therapeutic management. 1. Perkins GD, Callaway CW, Haywood K, et al. Brain injury after cardiac arrest. The Lancet. 2021;398(10307):1269-1278. doi:10.1016/s0140-6736(21)00953-3 2. Raffa GM, Agnello F, Occhipinti G, et al. Neurological complications after cardiac surgery: a retrospective case-control study of risk factors and outcome. Journal of Cardiothoracic Surgery. 2019;14(1)doi:10.1186/s13019-019-0844-8

Related Posts

See all Whitepapers
Mapping the Tau Cascade: New Insights from p-Tau 205 and p-Tau 212 for Disease Staging and Monitoring
Mapping the Tau Cascade: New Insights from p-Tau 205 and p-Tau 212 for Disease Staging and Monitoring

Mapping the Tau Cascade: New Insights from p-Tau 205 and p-Tau 212 for Disease Staging and Monitoring

Mapping the Tau Cascade: New Insights from p-Tau 205 and p-Tau 212 for Disease Staging and Monitoring
NPTX2: A Synaptic Biomarker of Circuit Integrity, Cognitive Resilience, and Neurodegeneration
NPTX2: A Synaptic Biomarker of Circuit Integrity, Cognitive Resilience, and Neurodegeneration

NPTX2: A Synaptic Biomarker of Circuit Integrity, Cognitive Resilience, and Neurodegeneration

Download Brochure
Advancing Translational Neuroscience with the Simoa Mammalian GFAP Assay
Advancing Translational Neuroscience with the Simoa Mammalian GFAP Assay Neurology

Advancing Translational Neuroscience with the Simoa Mammalian GFAP Assay

Publication Brief Understanding astrocyte biology is essential for advancing translational neuroscience. GFAP has emerged as a leading biomarker of CNS injury, and Simoa® technology now enables its ultra-sensitive detection directly…

Download Brochure
Proteomics in Transition: From Discovery to Diagnostic Relevance
Proteomics in Transition: From Discovery to Diagnostic Relevance

Proteomics in Transition: From Discovery to Diagnostic Relevance

Proteomics is moving beyond broad discovery to deliver real-time, clinically meaningful insights. At the forefront is Quanterix’s Simoa® digital immunoassay technology, enabling ultra-sensitive, reproducible detection of low-abundance biomarkers in areas…

Download Brochure
Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, and Tears
Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, and Tears Neurology

Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, and Tears

Publication Brief The Quanterix Simoa® platform, known for ultrasensitive detection in plasma, serum, and CSF, now delivers the same performance in alternative matrices—urine, saliva, sweat, and tears. This publication brief…

Download Brochure
Simoa® IL-17A Advantage PLUS: Potential Biomarker Applications in Health and Disease
Simoa® IL-17A Advantage PLUS: Potential Biomarker Applications in Health and Disease Immunology

Simoa® IL-17A Advantage PLUS: Potential Biomarker Applications in Health and Disease

App Note IL-17A is a potent pro-inflammatory cytokine that plays critical roles in inflammatory responses, host defense against infections, and tissue regeneration. This application note delves into the physiological and…

Download Brochure
Beyond Blood: Tear Fluid as a Window into Biomarker Discovery 
Beyond Blood: Tear Fluid as a Window into Biomarker Discovery  Neurology

Beyond Blood: Tear Fluid as a Window into Biomarker Discovery 

While blood and CSF have long dominated biomarker research, tear fluid is emerging as a scientifically relevant, non-invasive matrix for detecting systemic and neurological biomarkers. Produced by lacrimal glands and…

Beyond Blood: Tear Fluid as a Window into Biomarker Discovery 
Sweat As A Non-Invasive Matrix for Cytokine Detection Using Simoa® 
Sweat As A Non-Invasive Matrix for Cytokine Detection Using Simoa®  Neurology

Sweat As A Non-Invasive Matrix for Cytokine Detection Using Simoa® 

Inflammatory cytokines like IL-6, IL-10, and TNF-α are central to understanding aging, immune dysregulation, and chronic disease. With eccrine glands distributed across the body, sweat offers a non-invasive, physiologically relevant…

Sweat As A Non-Invasive Matrix for Cytokine Detection Using Simoa® 
See all Whitepapers